Approximately $50.0 million of net revenue from sales of LUMRYZ estimated for the fourth quarter, a greater than 150% increase over $19.5 million for the comparable period in 2023 -- --2,500 patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback